“…3,4 It was described as an indolent tumor with low malignancy potential and accounts for less than 0.5% of all sinonasal tumors. 5,6 There is a slight female predominance reported and it commonly occurs in patients in the sixth and seventh decades of age. 2,4 The common clinical manifestations include nasal obstruction and epistaxis.…”
Section: Discussionmentioning
confidence: 99%
“…It was first described by Stout and Murray in 1924 and was initially categorized as a hemangiopericytomalike neoplasm with perivascular myoid differentiation with a relatively benign clinical course . It was described as an indolent tumor with low malignancy potential and accounts for less than 0.5% of all sinonasal tumors . There is a slight female predominance reported and it commonly occurs in patients in the sixth and seventh decades of age .…”
“…3,4 It was described as an indolent tumor with low malignancy potential and accounts for less than 0.5% of all sinonasal tumors. 5,6 There is a slight female predominance reported and it commonly occurs in patients in the sixth and seventh decades of age. 2,4 The common clinical manifestations include nasal obstruction and epistaxis.…”
Section: Discussionmentioning
confidence: 99%
“…It was first described by Stout and Murray in 1924 and was initially categorized as a hemangiopericytomalike neoplasm with perivascular myoid differentiation with a relatively benign clinical course . It was described as an indolent tumor with low malignancy potential and accounts for less than 0.5% of all sinonasal tumors . There is a slight female predominance reported and it commonly occurs in patients in the sixth and seventh decades of age .…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.